Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02924688
Brief Title: A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

First Submitted : September 12, 2016
First Submitted that Met QC Criteria : October 3, 2016
First Posted : October 5, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 18, 2019
Last Update Posted : March 20, 2019